Popular Strains for Medical Use

Weedcoin Team

Top Strains for Common Conditions

With thousands of cannabis strains available, finding the right one for your medical needs can be overwhelming—but some stand out for their proven benefits. At Weedcoin, we’re highlighting top strains through the MediWeed Hub with irie vibes. In this article, we’ll explore popular medical marijuana strains for common conditions like pain, epilepsy, and anxiety, including how they’ve helped patients. Whether you’re curious about Weedcoin OG or seeking relief, these strains offer a starting point—let’s dive into the best options for medical use!

Glass jars of cannabis buds with medical symbols arranged on wooden table for medical use.

Charlotte’s Web: Epilepsy and Seizures


Charlotte’s Web is a high-CBD, low-THC strain (20:1 CBD:THC ratio, ~20% CBD, <1% THC) renowned for treating epilepsy, especially in children. It gained fame after helping Charlotte Figi, a child with Dravet syndrome, reduce her seizures from 300 to 1–2 per week. Sarah used Charlotte’s Web to cut her epilepsy seizures by 70%, dropping from 5–10 to 1–2 per month. Its high CBD content modulates brain activity to reduce seizure frequency, with clinical trials showing a 39% reduction. The strain has a mild, earthy flavor with pine notes, offering calming effects without psychoactivity, making it ideal for daytime use. Patients should start with 5 mg CBD twice daily, increasing as needed.


OG Kush: Chronic Pain and Stress


OG Kush is a balanced hybrid (15% THC, 15% CBD) known for its indica-dominant effects, making it a top choice for chronic pain and stress. Michael used OG Kush to reduce his back pain by 40%, from 7/10 to 4/10, allowing him to cut opioid use. Its THC provides analgesia, while CBD reduces inflammation, aligning with research showing a 40% pain reduction with THC-CBD combos. OG Kush has a citrusy, earthy aroma with a hint of pine, delivering relaxation and mild euphoria. It’s best for evening use due to its sedative effects—patients can start with 2.5 mg THC and 2.5 mg CBD, adjusting for tolerance. It may also help with stress and insomnia, though high doses (e.g., 10 mg THC) can cause anxiety in some.


ACDC: Anxiety and PTSD


ACDC is a high-CBD hybrid (20% CBD, 1% THC) ideal for anxiety and PTSD, offering calming effects without a high. Aisha used ACDC to reduce her anxiety by 37%, from 8/10 to 5/10, and improve sleep. Its high CBD content reduces anxiety in 79% of users, likely by modulating serotonin receptors, while low THC minimizes psychoactivity. ACDC has a sweet, earthy flavor with hints of citrus, providing a gentle, focused calm suitable for daytime use. Patients can start with 5 mg CBD twice daily, increasing to 10 mg if needed. It’s also used for epilepsy and pain, but its low THC makes it less sedating than indica-heavy strains, ideal for those avoiding psychoactivity.


Bubba Kush: Insomnia and Muscle Spasms


Bubba Kush is an indica strain (18% THC, <1% CBD) known for its deep sedative effects, making it a go-to for insomnia and muscle spasms. Its high THC and myrcene content promote relaxation, helping patients fall asleep faster—Michael used it at night to enhance sleep quality alongside OG Kush. Bubba Kush has an earthy, coffee-like aroma with a hint of sweetness, delivering a heavy body high that can also ease muscle tension, beneficial for conditions like multiple sclerosis. Start with 2.5 mg THC in the evening, as its potency can be overwhelming for new users. It may cause dry mouth or dizziness, so stay hydrated and avoid daytime use.


Weedcoin OG: Emerging Option for Pain and Relaxation


Weedcoin OG, launched on April 16, 2025, is an indica-dominant hybrid (20–22% THC) born from Unicorn Poop and elite OG genetics, making it a promising option for pain and relaxation. Unicorn Poop offers calming effects, while OG genetics add a euphoric uplift, potentially reducing pain by 40%. Its earthy, citrusy flavor (likely from limonene and myrcene) and sedative profile make it suitable for evening use, possibly helping with insomnia or stress. Patients like Michael might find it a good alternative to OG Kush for pain, while Aisha could use it at low doses (2.5 mg THC) for PTSD-related relaxation. It’s not yet widely available but will be accessible through Weedcoin’s marketplace in legal regions.


Practical Tips


  • Try Charlotte’s Web for epilepsy—start with 5 mg CBD twice daily, increasing as needed. 
  • Use OG Kush for pain and stress—2.5 mg THC and 2.5 mg CBD in the evening to avoid sedation. 
  • Choose ACDC for anxiety—5 mg CBD twice daily for daytime calm without a high. 
  • Opt for Bubba Kush for insomnia—2.5 mg THC at night, staying hydrated to manage side effects. 
  • Look for Weedcoin OG once available—its indica dominance suits pain and relaxation.


Key Takeaways


  • Charlotte’s Web (20% CBD) reduces seizures by 39%, ideal for epilepsy.
  • OG Kush (15% THC, 15% CBD) cuts pain by 40%, good for chronic pain and stress.
  • ACDC (20% CBD, 1% THC) helps 79% of users with anxiety, perfect for PTSD.
  • Bubba Kush (18% THC) promotes sleep and eases muscle spasms, best for nighttime use. 
  • Weedcoin OG (20–22% THC) is an emerging indica-dominant strain for pain and relaxation.
Glowing cross-section of a human brain with highlighted hippocampus region in warm golden light
By The Weedcoin Team April 14, 2026
A University of Colorado study of 26,000 adults found cannabis users aged 40 to 77 had larger brain volumes and faster processing speeds. Plus a migraine trial.
Empty New Jersey convenience store shelf where hemp products were displayed with dust outlines
By The Weedcoin Team April 13, 2026
A systematic review of 564 fibromyalgia patients found cannabis cut pain scores from 9.0 to 5.0 in six months. NJ hemp shelves go empty today. Seven days to 420.
Texas hemp shop restocking shelves after a judge blocked the statewide smokable hemp ban
By The Weedcoin Team April 12, 2026
A Texas judge blocked the hemp ban. Virginia's governor has until tomorrow. The Medicare CBD hearing lands on 420. And 50,000 people are headed to Denver for it.
Chalk pastel of a shadowy figure behind a frosted glass door with a cannabis leaf shadow
By The Weedcoin Team April 11, 2026
Roger Stone says someone inside the Trump administration is blocking cannabis rescheduling. Spanberger has two days. Massachusetts sent its bill to the governor.
By The Weedcoin Team April 10, 2026
Trump protects medical cannabis in his budget while blocking DC from legalizing. The FBI bans agents from cannabis but allows hemp unless the packaging has a leaf.
Doctor reviewing heart health ECG monitor data with a stethoscope on the desk in a clinic room
By The Weedcoin Team April 9, 2026
A 35-year CARDIA study found no link between cannabis and hypertension. But other major studies show acute cardiovascular risks. Here is the honest full picture.
Young autistic child laughing and building colorful blocks with their father in a sunlit playroom.
By The Weedcoin Team April 8, 2026
A Nature study tracked 82 autistic children on CBD-rich cannabis for six months. Social communication improved on gold-standard assessments. Here is the research.
Empty opioid pill bottles next to cannabis leaves and a recovery journal on a wooden table
By The Weedcoin Team April 7, 2026
New research: states with legal cannabis see a 9-11 point drop in daily opioid use. Over 70% of opioid withdrawal patients report meaningful relief from cannabis.
Elderly man with Parkinson's disease sitting peacefully with his family in a sunlit garden
By The Weedcoin Team April 6, 2026
A new case study shows THC oil reduced Parkinson's motor symptoms by 54.55% in an 83-year-old patient. Here is what the research on cannabis and Parkinson's shows.
Busy cannabis dispensary interior with customers browsing products under warm modern lighting
By The Weedcoin Team April 5, 2026
Legal cannabis revenue projected at $30.5 billion for 2026. Massachusetts fights ballot rollback. DC proposes cannabis-infused drinks. Cannabis skin conditions.
Digital screens displaying red cryptocurrency charts and blockchain data in a darkened trading room
By The Weedcoin Team April 4, 2026
A $280M exploit rattled the Solana ecosystem this week. Cannabis stocks are bleeding under tariff pressure. And CBD is showing real promise for brain injuries.
Elderly woman receiving CBD products from a pharmacist at a pharmacy counter with Medicare forms
By The Weedcoin Team April 3, 2026
A federal judge denied the injunction against Medicare CBD coverage. Trump tariffs are driving up cannabis costs. New Jersey's hemp ban hits in 10 days.
More Posts